Open in interactive viewer → charts, metric popovers & call review

Stoneridge: The Divestiture-Fueled Reinvention Is Talking the Talk — Now the Margins Walk It

After selling Control Devices, a small-cap auto-tech pure play bets its turnaround on MirrorEye, a 400bp gross-margin inflection, and the tariff-refund wave washing through the sector.
SRI · Earnings Call · 2026-05-08

The New Shape of Stoneridge

Stoneridge entered 2026 as a different company. The January 30 sale of its Control Devices business forced a retrospective restatement with the segment reclassified as discontinued operations, and new CEO Natalia Noblet opened her first call by framing the quarter as “the next phase of our long-term strategy as we advance our key priorities to drive shareholder value” — Natalia Noblet, President and Chief Executive Officer · 2026-05-08. The sale of Control Devices is more than an accounting footnote — it converts what was a cyclical auto-parts conglomerate into a focused auto-technology play: MirrorEye camera mirror systems, electronic controls, and the fast-growing Brazilian OEM business. The economics of that pivot are visible in the mix: while total revenue fell 26% year over year, gross profit actually rose 12% — a margin-mix shift that would have been unthinkable with the legacy business attached. That spread — revenue down, gross profit up — is the cleanest evidence that what remains is structurally better. Stoneridge Brazil OEM sales grew more than 54% in the quarter, off-highway improved, and management claims first-quarter revenue grew 9.2% sequentially while their weighted OEM end market 'declined by 9.1% over the same period.' On the prior call in March, management had framed 2026 as a year of recovery with IHS forecasts at +7.1%; they now cite revised forecasts of just +1.8% — a gap management quietly closes via product cycle rather than macro. It is the same market outperformance language the company has used for several quarters, but now it is coming with actual margin receipts.

The Margin Inflection Is Real — and Paying Down Debt

The headline is the gross margin. Adjusted gross margin expanded 400 basis points sequentially on manufacturing performance, quality-cost reduction, and — critically — the tariff-refund wave washing through the sector. CFO Bob Hartman quantified it: “we recognized a favorable net tariff benefit during the quarter resulting from both customer reimbursement agreements and IEEPA tariff refunds” — Robert Hartman, Chief Financial Officer · 2026-05-08. This is not a company-specific accident. IEEPA refund is a consensus theme across the 2026Q3 reporting season — from shelf-stock players to medical-device firms, 'tariff refunds' sit near the top of dozens of company keyword boards, and the global tape shows a whole 'tariff refund benefit' cluster. Stoneridge is riding the same wave as the rest of the market. The raw numbers confirm the story is genuine rather than optics: gross margin printed 21.7% in 2026Q1 versus 16% the prior quarter, and operating margin improved from -15% to -8%. The 600 basis points of raw improvement is the sharpest quarterly move since 2020. That drove “adjusted EBITDA of $2 million, which exceeded our previous expectations of approximately breakeven performance” — Robert Hartman, Chief Financial Officer · 2026-05-08. Management is also leaning on belt-tightening — a structural cost reduction of at least $5M this year — and it shows in cash flow discipline: inventory is down roughly $16M year over year, and conservative spend had capex collapse to under $1M in the quarter. The balance sheet, battered for years, is in repair mode. Proceeds from the Control Devices sale paid down debt, with net debt improving about $42 million sequentially to -$86 million. Net cash improved $42M quarter-over-quarter as sale proceeds flowed to the credit facility. Management has initiated a refinancing and targets completion by November, aiming to replace the amended facility (extended to July 2027) with a structure 'more aligned with the long-term structure of the company.' The cash flow conversion theme threading through recent calls is finally being realized on a de-levered base.

MirrorEye Reaches Terminal Velocity

The product cycle is doing the heavy lifting. MirrorEye notched another quarterly sales record at $33 million (+11% QoQ, +32% YoY), with the company crossing 150,000 systems produced globally. The strategic prize, though, is the order book.

We are excited to announce 2 major business awards totaling approximately $135 million of estimated lifetime revenue. First, we are announcing an award for an OEM integrated MirrorEye program with our fourth North American customer. We now have OEM programs with all 4 major Class 8 truck manufacturers in North America.

Natalia Noblet, President and Chief Executive Officer · 2026-05-08
A second award — a next-generation control program for a European off-highway maker launching in 2028 — adds $65M of lifetime revenue. These business awards complete the MirrorEye moat: every major North American Class 8 OEM is now an integrated customer, a trajectory that has been building through years of 'standard equipment' launches at Volvo and Daimler — the very standard equipment theme that drove the stock's narrative in prior quarters.

Guidance at Arm's Length

The stubborn honesty is in the guidance. Full-year revenue guidance was adjusted down by $20M to $645–$670M, and adjusted operating margin trimmed to roughly breakeven-to-0.5% — but that is largely accounting: the $3.8M of Mexico supply agreement contract-manufacturing revenue related to the Control Devices sale is now classified as revenue rather than other income, keeping adjusted EBITDA ($20–$25M) unchanged. Management expects second-quarter revenue 'slightly above' the first, with EBITDA weighting to the back half on material and structural cost ramps — a cadence that, if it holds, turns this quarter's inflection into a sustained trajectory rather than a one-off refund pop.